Latest 5 articles from heartwire
- Air pollutants mediate effects on heart health through inflammation and thrombosis
May 17, 2012 17:15 EDT - Statins benefit those at much lower CV risk
May 16, 2012 18:30 EDT - Azithromycin may up chance of sudden cardiac death
May 16, 2012 17:00 EDT - So long, Plavix, what a ride! Clopidogrel patent expires
May 16, 2012 14:45 EDT - COMFORTABLE-AMI: Bioerodable polymer DES trumps bare metal in STEMI
May 16, 2012 10:50 EDT
STICH, EVEREST, RIVAL, and top interventional trials from ACC 2011
Posted Apr 04, 2011
at 11:00 PM, EDT
by Steven Rourke
The STICH trial (reporting on CABG in HF patients), EVEREST (on MitraClip vs surgery), and a host of interventional trials were top news today at American College of Cardiology (ACC) 2011 Scientific Sessions. Learn the essentials.
See:
Docs say STICH "hypothesis one" supports CABG in HF patients despite missing primary end point
Latest from EVEREST II: MitraClip less effective but safer than surgery
Everolimus-eluting stent performs well in PLATINUM
PRECOMBAT: PCI noninferior to CABG for left main disease, but questions linger
Five-year data favor radial artery over saphenous vein grafts for CABG
Radial RIVALs femoral access for invasive ACS treatment, but doesn't beat it
New Resolute zotarolimus stent data flesh out efficacy, safety
Previous posts
"Consent the stent" campaign--long overdue!
No comments |
Posted May 09, 2012
at 10:05 PM, EDT by Melissa
at 10:05 PM, EDT by Melissa
Hospital interest rates: Taking the family farm
10 Comments |
Posted Apr 24, 2012
at 08:22 PM, EDT by Melissa
at 08:22 PM, EDT by Melissa
Dr Dean Ornish with manna for the masses
16 Comments |
Posted Mar 28, 2012
at 10:05 AM, EDT by Melissa
at 10:05 AM, EDT by Melissa
Physicians remember: Mainstream-medicine haters are people too
24 Comments |
Posted Mar 27, 2012
at 12:37 PM, EDT by Melissa
at 12:37 PM, EDT by Melissa
All natural? $15 billion worth sold annually
19 Comments |
Posted Mar 27, 2012
at 12:36 AM, EDT by Melissa
at 12:36 AM, EDT by Melissa
Also from theheart.org















Comments